Caricamento...
Effects of acute glucocorticoid blockade on metabolic dysfunction in patients with Type 2 diabetes with and without fatty liver
To investigate the potential of therapies which reduce glucocorticoid action in patients with Type 2 diabetes we performed a randomized, double-blinded, placebo-controlled crossover study of acute glucocorticoid blockade, using the glucocorticoid receptor antagonist RU38486 (mifepristone) and cortis...
Salvato in:
Autori principali: | , , , , , , , , |
---|---|
Natura: | Artigo |
Lingua: | Inglês |
Pubblicazione: |
American Physiological Society
2014
|
Soggetti: | |
Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4187063/ https://ncbi.nlm.nih.gov/pubmed/25104497 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1152/ajpgi.00030.2014 |
Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|